Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT Adjuvant Patch with H5N1 Vaccine in Healthy Adults
NCT00908687Phase 2Completed
- Sponsor
- Intercell AG
- Start
- May 2009
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Vaccine Enhancement Patch in Avian influenza A H5N1 infection (H5N1), sponsored by Intercell AG. Started May 2009; status: completed.
02
Drugs
Vaccine Enhancement Patch
03
Conditions
Avian influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT00908687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908687.